Literature DB >> 31917173

Eradication of BRAF K601E Mutation in Metastatic Castrate-resistant Prostate Cancer Treated With Cabazitaxel and Carboplatin: A Case Report.

Peter Steinwald1, Elisa Ledet1, Oliver Sartor2.   

Abstract

Entities:  

Keywords:  PSA; Platinum; Precision medicine; Prostate cancer; mCRPC

Mesh：

Substances：

Year:  2019        PMID： 31917173     DOI： 10.1016/j.clgc.2019.12.015

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN： 1558-7673            Impact factor:   2.872


× No keyword cloud information.
  2 in total

Review 1.  The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer.

Authors:  Giovanni Maria Iannantuono; Francesco Torino; Roberto Rosenfeld; Simona Guerriero; Manuela Carlucci; Stefano Sganga; Barbara Capotondi; Silvia Riondino; Mario Roselli
Journal:  Int J Mol Sci       Date:  2022-08-01       Impact factor: 6.208

2.  PIN-like ductal carcinoma of the prostate has frequent activating RAS/RAF mutations.

Authors:  Harsimar B Kaur; Daniela C Salles; Adina Paulk; Jonathan I Epstein; James R Eshleman; Tamara L Lotan
Journal:  Histopathology       Date:  2020-09-24       Impact factor: 5.087
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.